To improve the quality of life and outcomes for patients affected by Acute Respiratory Distress Syndrome (ARDS) through education, advocacy, research funding, and comprehensive support for patients and their families. We are committed to advancing ECMO technology and ensuring access to life-saving treatments for all who need them.